Rescue Therapy in Patient with Glioblastoma Multiforme Combining Chemotherapy, Hyperthermia, Phytotherapy
Journal Title: Journal of Integrative Oncology - Year 2017, Vol 6, Issue 4
Abstract
Glioblastoma multiforme is a pathology that is poorly treatable and tends towards recurrence. If surgically unresectable, at least without macroscopically visible residue, the prognosis is severe. Here is the case of a 60-yearold woman suffering from recurrent glioblastoma who comes to my observation with no therapeutic options and treated with a combination of antiangiogenic drug, RF capacitive hyperthermia and herbal medicine, earns an acceptable quality of life and survival prolongation of six months.
Authors and Affiliations
Carlo Pastore, Massimo Fioranelli, Maria Grazia Roccia
Keywords
Related Articles
- EP ID EP348678
- DOI 10.4172/2329-6771.1000199
- Views 76
- Downloads 0
Reiki Therapy is Credible in Oncology. A Possible Analysis...
In an earlier article by the author, the effectiveness and efficacy of Reiki Therapy when used as complementary therapy in patients with blood cancer was demonstrated. With the present article, the author invites readers...
A Red Skin Nodule
A 78-year-old woman presented with a 2-month-history of a cutaneous red nodule on her left leg (Figure 1). Differential diagnosis of nodular red lesions includes dermal nevus, pyogenic granuloma, angioma, amelanotic mela...
Homeopathy: Curative, Concurrent and Supportive Cancer Treatment Potential
Background: Homeopathy is used by 12 to 24% of European cancer patients, representing 40.4% of patients at European integrative cancer centers. In 2011, a Swiss literature review on homeopathy led to homeopathic treatmen...
Approximation to the Patient with Tumor of Unknown Origin
The tumor of unknown origin constitutes 3-7% of the cancers studied and is one of the 10 most frequent cancer diagnoses. It is a malignant tumor whose first origin or identification is not done in the clinical history, i...
Second Primary Neoplasms: A Clinico-Pathological Analysis from a Sub Himalayan Cancer Centre in India
Background: There is a lifetime risk of developing another de novo malignancy in diagnosed cancer patients. Detection of new primary has increased due to advances in both diagnostic and treatment modalities. This article...